COVID-19 Ag Test For use by professionals for nasal or nasopharyngeal swab

Humasis COVID-19 Ag Test

  • Testing is very simple, performed by a nasal swab or a nasopharyngeal swab followed by screening on a test device
  • Nasal/Nasopharyngeal swab: cl. sensitivity more than 95 %, cl. specificity 100,00 %
  • The test shows the same sensitivity and specificity for new virus variants
  • Results are apparent between 15 to 20 minutes
  • Tests are made in South Korea
  • Humasis COVID-19 Ag Test in on the HSC list and has got the HSC mutual recogniton

Humasis Ag Tests can also be purchased at a regular pharmacy network,
where they are delivered through an Alliance Healthcare distributor

Authorized distributors: Novatin s.r.o., phone n. +420 724 510 412,

Humasis COVID-19 Ag Test

Product information


    Humasis COVID-19 Ag Test uses monoclonal antibodies specific to COVID-19 antigens to detect COVID-19 specific antigens in human nasal swab and nasopharyngeal swab specimens.

    The test results are more accurate because the test contains 2 antibodies - monoclonal antibody against SARS-CoV-2 nucleocapsid and monoclonal antibody specific to RBD against SARS-CoV-2 spike protein, most manufacturers use only one Ab.

    A nitrocellulose membrane strip in the device contains one test line and one control line. The test line is pre-coated with anti-mouse monoclonal antibody to SARS-CoV-2 nucleocapsid and RBD for detection of SARS-CoV-2 antigens, and the control line is coated with goat anti-mouse IgG.

    When the extracted swab specimen is added to the sample well, it will migrate to the conjugate pad, which contains conjugated antibodies conjugated with colloidal gold directed against the SARS-CoV-2 antigen. If the sample contains SARS-CoV-2 antigens, antigen-antibody-conjugate complex will be formed. The complex will continue to migrate across the membrane until it reaches the capture zone (test line) where the complex will bind to immobilized antibodies and form visible colored band in the test line. The sample will continue to move along the membrane until it reaches the control line where excess conjugate binds and produces a second visible line. This control line indicates that the sample has migrated across the membrane as intended and the test was performed properly.

    Package contents

    • 25 tests/package
    • Test device packaged individually in aluminium pouch (25 tests/box)
    • Disposable test tube with extraction buffer (25 ea/box)
    • Filter cap (25 ea/box)
    • Sterilised swabs for specimen collection (25 ea/box)
    • Instructions for use (1ea)




    2-30 °C


    18 months


    Related products

    COVID-19 Flu Ag Combo Test – Humasis

    Humasis COVID-19/Flu Ag Combo Test is one step in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of SARS-CoV-2 antigens and influenza A/B antigens in nasopharyngeal swab specimen of suspected patients.

    Humasis COVID-19 IgG/IgM Test

    Humasis COVID-19 IgG/IgM test is one step in vitro diagnostic test based on an immunochromatographic assay. It is designed for qualitative detection of Immunoglobulin G and Immunoglobulin M antibody of Novel Coronavirus (COVID-19) in human whole blood, plasma or serum.

    Information video

    Test Humasis COVID-19 Ag

    Watch the video with presentation of product packaging and its use.